Emerging Comorbidities in Adult Asthma: Risks, Clinical Associations, and Mechanisms
Open accessThe DOI matches its Crossref record; 220 of the 220 references it cites were found in a registry or an index.
Abstract
Asthma is a heterogeneous disease with many phenotypes, and age at disease onset is an important factor in separating the phenotypes. Most studies with asthma have been performed in patients being otherwise healthy. However, in real life, comorbid diseases are very common in adult patients. We review here the emerging comorbid conditions to asthma such as obesity, metabolic syndrome, diabetes mellitus type 2 (DM2), and cardiac and psychiatric diseases. Their role as risk factors for incident asthma and whether they affect clinical asthma are evaluated. Obesity, independently or as a part of metabolic syndrome, DM2, and depression are risk factors for incident asthma. In contrast, the effects of comorbidities on clinical asthma are less well-known and mostly studies are lacking. Cross-sectional studies in obese asthmatics suggest that they may have less well controlled asthma and worse lung function. However, no long-term clinical follow-up studies with these comorbidities and asthma were identified. These emerging comorbidities often occur in the same multimorbid adult patient and may have in common metabolic pathways and inflammatory or other alterations such as early life exposures, systemic inflammation, inflammasome, adipokines, hyperglycemia, hyperinsulinemia, lung mechanics, mitochondrial dysfunction, disturbed nitric oxide metabolism, and leukotrienes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Barnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S., & Guthrie, B. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60240-2 · Cited by 6,972
PAUWELS, R. A., BUIST, A. S., CALVERLEY, P. M. A., JENKINS, C. R., & HURD, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,587
Effect of In Utero and Early-Life Conditions on Adult Health and Disease
Gluckman, P. D., Hanson, M. A., Cooper, C., & Thornburg, K. L. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0708473 · Cited by 3,898 · cited 1×
“For example, epigenetic modifications such as DNA or histone methylation and histone acetylation in foetal genes important for lipid or carbohydrate metabolism or immune system are likelymechanisms involved in explaining later risk and higher occurrence of many metabolic and other chronic diseases [133].”
BackgroundGuh, D. P., Zhang, W., Bansback, N., Amarsi, Z., Birmingham, C. L., & Anis, A. H. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-88 · Cited by 3,855
(1989) · PubMed · Cited by 3,139
THE ATHEROSCLEROSIS RISK IN COMMUNIT (ARIC) STUDY: DESIGN AND OBJECTIVES
THE ARIC INVESTIGATORS (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115184 · Cited by 2,924
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511 · cited 1×
“IL-6 may affect asthma development, for example, by stimulating neutrophil recruitment and T helper cell differentiation into Th2 or Th17 cells (the latter in the presence of TGF-β) or by stimulating IL-13 production by T helper cells [142, 143].”
BackgroundAsthma phenotypes: the evolution from clinical to molecular approaches
Wenzel, S. E. (2012) · Nature Medicine · doi:10.1038/nm.2678 · Cited by 2,412
Mitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107 · cited 1×
“Similar changes in mitochondrial function occur in older age [198].”
BackgroundGlobal asthma prevalence in adults: findings from the cross-sectional world health survey
To, T., Stanojevic, S., Moores, G., Gershon, A. S., Bateman, E. D., Cruz, A. A., & Boulet, L.-P. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-204 · Cited by 1,521 · cited 4×
“[1 29 –1 33 ]”
Influential
Research works printed but not linked: 6
Cited by
Items 101–121 of 121
The Post-hunter-gatherer Era Microbes Hypothesis for Chronic Inflammatory DiseasesPreprint
Waterhouse, J. C. (2020) · doi:10.22541/au.160614799.98699073/v1
Indicators of metabolic syndrome in normotensive normoglycemic asthmatic patients
Sourg, H. A. A., Ahmed, A. B. M., Elhakeem, R. F., & Lutfi, M. F. (2020) · Journal of Clinical and Translational Research · doi:10.18053/jctres.06.202001.005 · Cited by 2
A STUDY ON CORRELATION BETWEEN BRONCHIALASTHMA CONTROLAND BODY MASS INDEX
Rashmi, C., Mascarenhas, D. G., & Bm, V. (2020) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/3701391
Айсанов, З. Р., Kurbacheva, O. M., Emelyanov, A. V., Ignatova, G. L., Teichman, L., Makarova, J., Fedosenko, S. V., Alfonso, R., & Elfishawy, T. (2021) · Research Square · doi:10.21203/rs.3.rs-1027666/v1
Kapfhammer, H. (2022) · Springer eBooks · doi:10.1007/978-3-662-65873-4_5
Asma en el adulto: características clínicas, comorbilidades y riesgo para apnea obstructiva de sueño
Cáceres, R., Castro, A., Bentos, R., Centurión, C., Guccione, A., Cuenca, E., Arbo, G., Lemir, R., & Bejarano, D. P. (2023) · Revista científica ciencias de la salud · doi:10.53732/rccsalud/2023.e5111
Incidence of treatment-resistant depression during the first mood depressive episode.
Said, M., Hosni, R., Jemli, H., Zgueb, Y., Ouali, U., Zalila, H., Nacef, F., & Jomli, R. (2023) · PubMed Central
Charnolosome nanotheranostics in pulmonary diseases
Sharma, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21752-4.00035-3
Banta, J. E., Egiebor, I. C., Grismore, C., Westbrook, M., & Banta, J. M. (2024) · doi:10.37349/eaa.2024.00064
Obesity predicts mortality stronger in adult‐onset asthma than in age‐ and sex‐matched controls
Bäckman, H., Stridsman, C., Lindberg, A., Rönmark, E., & Hedman, L. (2024) · Clinical and Translational Allergy · doi:10.1002/clt2.70011
Obesity and Weight Change in Relation to Asthma Incidence: An 8-Year Longitudinal StudyPreprint
Abohalaka, R., Ercan, S., Ilmarinen, P., Bäckman, H., Ekerljung, L., Rådinger, M., Nwaru, B. I., & Kankaanranta, H. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5166251
Self-citationYang, F., Zheng, J., Gao, M., & Ning, L. (2025) · Journal of Asthma · doi:10.1080/02770903.2025.2577637
“Asthma is often comorbid with conditions like diabetes (22).”
DeChristopher, L. R., & Tucker, K. L. (2020) · Figshare · doi:10.6084/m9.figshare.12552527
Wee, J. H., Min, C., Park, M. W., Byun, S. H., Lee, H., Park, B., & Choi, H. G. (2020) · Figshare · doi:10.6084/m9.figshare.13010778
Takala, J., Vähätalo, I., Tuomisto, L. E., Niemelä, O. J., Ilmarinen, P., & Kankaanranta, H. (2022) · Figshare · doi:10.6084/m9.figshare.19220935
Self-citationKim, Y., Kim, I., Yoo, J. W., Chung, T., Brown, L., Kwak, I., & Moonie, S. A. (2026) · Respiratory Medicine · doi:10.1016/j.rmed.2026.108871
Sanap, S. S., Gupta, K. R., Kabra, U. D., & Umekar, M. J. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12357-x
“The combination of digital health technologies, environmental regulation strategies, and personalized medicine practices is the key to the future of comprehensive and efficient asthma management [ 33].”
Rajput, R. P., Kaur, S., Ingole, Y., Khandale, N. B., Birla, D., Pandey, N. K., Bansal, S., Monika, Sharma, P., & Kukreti, N. (2026) · AIP conference proceedings · doi:10.1063/5.0286707
Oka, V., Archibong, A., Nku-Ekpang, O.-A. T., Umoh, E., & Owu, D. (2026) · F1000Research · doi:10.12688/f1000research.188666.1
Cao, J., Hamano, T., Yang, H., Jansåker, F., Sundquist, K., Sundquist, J., Zhang, Y., & Li, X. (2026) · Respiratory Research · doi:10.1186/s12931-026-03927-5
“Extensive epidemiological research has established associations between asthma and comorbidities such as metabolic syndrome, chronic obstructive pulmonary disease (COPD), and cardiovascular diseases [4, 5].”
Metadata
- Authors
- Kankaanranta, H., Kauppi, P., Tuomisto, L. E., & Ilmarinen, P.
- Affiliations
- Seinäjoen Keskussairaala (FI)
- University of Helsinki (FI)
- Corresponding author
- Kankaanranta, Hannu
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2016
- Volume
- 2016
- Pages
- 1-23
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- PMC
- PMC4861800
- OpenAlex
- W2343516313
- Cited by
- 122
- References
- 219
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 12 · 2023: 11 · 2022: 13 · 2021: 16 · 2020: 17 · 2019: 13 · 2018: 12 · 2017: 6 · 2016: 5
- FWCI
- 1.41
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Mediators of Inflammation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Tampere University Institutional Repository (Tampere University) (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Työväentutkimus Vuosikirja (submittedVersion)
- Tampere University Institutional Repository (Tampere University) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- adult asthma, comorbidities, obesity, metabolic syndrome, type 2 diabetes, depression, heart disease, asthma risk factors, asthma control, lung function, systemic inflammation, adipokines, hyperinsulinemia, hyperglycemia, mitochondrial dysfunction, nitric oxide metabolism, leukotrienes, early life exposure, asthma phenotypes
- MeSH terms
- Animals, Asthma, Depression, Diabetes Mellitus, Type 2, Humans, Obesity, Risk Factors, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
